What is C Light Technologies?
C Light Technologies operates at the vanguard of medical diagnostics, utilizing high-resolution retinal eye-tracking to monitor neurological conditions. By transforming the eye into a window for brain health, the company provides a scalable, AI-driven platform that assists healthcare providers in assessing patient responses to therapeutic interventions. This market position is bolstered by a robust intellectual property portfolio and a strategic focus on deep-tech applications that address global-scale healthcare challenges. The company's methodology bridges the gap between complex neuro-scientific research and practical, clinical-grade diagnostic tools, effectively disrupting traditional, subjective neurological assessment protocols.
How much funding has C Light Technologies raised?
C Light Technologies has raised a total of $2.5M across 1 funding round:
Angel/Seed
$2.5M
Angel/Seed (2021): $2.5M with participation from Vectors Angel Group, Wisconsin Investment Partners, Berkeley Skydeck Fund, Monde Green Ventures, Puck Ventures, EGB Capital, Band of Angels, Yamaha Motor Ventures & Laboratory Silicon Valley, and Creative Ventures
Key Investors in C Light Technologies
Wisconsin Investment Partners
Wisconsin Investment Partners is a prominent angel investment group and business incubator that provides essential capital and strategic support to early-stage ventures.
Band of Angels
As Silicon Valley's oldest angel investment group, the Band of Angels leverages a network of over 150 high-tech executives to provide mentorship and funding to life science and technology startups.
Creative Ventures
Creative Ventures is a method-driven venture capital firm that focuses on scalable, deep-tech solutions to global-scale challenges, utilizing a rigorous, market-first investment protocol.
What's next for C Light Technologies?
With the infusion of recent capital, C Light Technologies is poised to accelerate its clinical validation studies and expand its commercial footprint. The strategic roadmap likely involves scaling its AI infrastructure to support broader diagnostic applications and deepening partnerships with pharmaceutical entities interested in objective medication efficacy data. As the company transitions from its foundational development phase into a more mature enterprise-level operation, the focus will shift toward regulatory milestones and the integration of its technology into standard clinical workflows. This expansion is supported by a diverse syndicate of investors who bring not only financial resources but also deep operational expertise in the life sciences and deep-tech sectors.
See full C Light Technologies company page
